Decoding clinical trials in Australia using

Decoding clinical trials in Australia using

Facebook Group

Posted 2024-02-21 by Vanessafollow is the market leader clinical trial predictor with an accuracy rate of +90%.

Every new drug or medical device needs to qualify through a clinical trial before market launch. However, the methods used to design clinical trials can be slow-moving, expensive, and lack transparency for patients. As a result, only 10% of pivotal clinical trials succeed, with an average cost of $48 million.

But that's all set to change with - an easy-to-use platform that uses artificial intelligence (AI) to empower patients, healthcare professionals, clinical research organisations (CROs), and pharmaceutical manufacturers to make more informed decisions towards better medical outcomes.

TrialKey delivers tailored, actionable steps to address critical trial challenges, thereby optimising trial designs and increasing the likelihood of its success.

Access to these insights enables CROs and pharmaceutical companies to quickly identify inefficiencies, streamline workflows, and improve clinical trial designs, ultimately reducing time to market while enhancing its chances to pass its current phase.

TrialKey pulls data from an extensive database of over 65,000 clinical trials spanning over 20 years. It leverages the power of AI and GPT-4 to analyse this data through over 500+ variables including drug parameters.

4,189 clinical trials were utilized to assess TrialKey's algorithm precision and recall accuracy. The model then simulates a probability distribution and evaluates the potential outcomes of the clinical trial passing its current phase.

Each trial in the dataset was simulated 100 times for a comprehensive understanding of its predicted success rates.

Through this comprehensive process, TrialKey accurately provides users with not only success rate predictions, but also in-depth insights on areas of improvement, enabling clinicians to address loopholes in trials faster, with higher precision.

On the platform, users will be able to sort and filter through clinical trials by relevance to their search query, status, estimated completion date, sponsor name, and success probability.

What benefits does provide users?
By employing AI and GPT-4 to analyze real-world trial data, can provide users with:
  • An estimate of the probability of success for a clinical trial
  • Actionable insights aimed at enhancing every facet of trial design.
  • An AI-driven clinical trial search function facilitating the identification of relevant trials and their closest competitors.
  • Identification of promising areas of research
  • Detailed timelines, and estimated probabilities of success for ongoing trials for an area of research

  • What do these TrialKey benefits mean for me?
  • Patients and caregivers can explore potential treatment options and understand the likelihood of success in clinical trials.
  • Healthcare professionals can make data-driven decisions and treatment recommendations using as a valuable resource.
  • Clinicians from CROs can identify inefficiencies, streamline workflows, and improve clinical trial designs, ultimately reducing time to market and boosting success rates.
  • Investors and analysts can independently verify data provided by CROs and pharmaceutical companies, making more informed business decisions.

  • As a testament to its reliability, TrialKey accurately forecasted the success of the Moderna and Pfizer vaccines during the COVID-19 pandemic before their clinical trials concluded. This success underscores TrialKey's potential to empower patients, healthcare professionals, clinical researchers, and investors with the foresight needed for effective decision-making.

    The TrialKey team is constantly working on adding new features to provide the best, and most convenient experience for their users, whether that be patients, their doctors, clinical trial organisations, pharmaceutical manufacturers, or investors.

    Want to learn more?
    Join us towards more efficient and successful clinical trials.
    Sign up for free at
    You can book in a free demo at
    For any questions, please email [email protected]
    For any marketing or press enquiries please email Bernice Averion at [email protected]

    276477 - 2024-01-29 06:27:33


    Copyright 2024 OatLabs ABN 18113479226